Hyperthyroidism affects arterial stiffness, plasma NT-pro-B-type natriuretic peptide levels, and subendocardial perfusion in patients with Graves' disease

Annals of Medicine

Volumn 39, Issue 8, 2007, Pages 608-616

  Bodlaj, Gerd ^a   Pichler, Robert ^a   Brandstätter, Walter ^a   Hatzl Griesenhofer, Margit ^a   Maschek, Wilhelmine ^a   Biesenbach, Georg ^a   Berg, Jörg ^a  

^a KEPLER UNIVERSITY HOSPITAL   (Austria)

Author keywords

Graves' disease; Hyperthyroidism; NT ProBNP; Subendocardial perfusion; Systemic arterial stiffness

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADOLESCENT; ADULT; AGED; AORTIC AUGMENTATION INDEX; ARTERIAL STIFFNESS; ARTERY DISEASE; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; EUTHYROIDISM; FEMALE; GRAVES DISEASE; HEART PERFUSION; HEART RATE; HOMEOSTASIS; HUMAN; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCORING SYSTEM; TONOMETRY;

ADOLESCENT; ADULT; AGED; ARTERIES; ELASTICITY; FEMALE; GRAVES DISEASE; HUMANS; HYPERTHYROIDISM; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; THYROXINE; TRIIODOTHYRONINE;

EID: 36448937135     PISSN: 07853890     EISSN: 16512219     Source Type: Journal    
DOI: 10.1080/07853890701528579     Document Type: Article

References (41)

1. Chopra IJ, Solomon DH. Pathogenesis of hyperthyroidism. Annu Rev Med. 1983;34:267-81.
2. Klein I, Ojamaa K. Thyroid hormone and the cardiovascular systeme. N Engl J Med. 2001;344:501-9.
3. Polikar R, Burger AG, Scherrer U, Nicod P. The thyroid and the heart. Circulation. 1993;87:1435-41.
4. Kahaly GJ, Dillmann WH. Thyroid hormone action in the heart. Endocr Rev. 2005;26:704-28.
5. Toft AD, Boon NA. Thyroid disease and the heart. Heart. 2000;84:455-60.
6. Volzke H, Robinson DM, Schminke U, Ludemann J, Rettig R, Felix SB, et al. Thyroid function and carotid wall thickness. J Clin Endocrinol Metab. 2004;89:2145-9.
7. Inaba M, Henmi Y, Kumeda Y, Ueda M, Nagata M, Emoto M, et al. Increased stiffness in common carotid artery in hyperthyroid Graves' disease patients. Biomed Pharmacother. 2002;56:241-6.
8. Czarkowski M, Hilgertner L, Powalowski T, Radomski D. The stiffness of the common carotid artery in patients with Graves' disease. Int Angiol. 2002;21:152-7.
9. 1-adrenergic blockade. Eur J Endocrinol. 2004;150:757-62.
10. O'Rourke MF, Kelly RP. Wave reflection in the systemic circulation and its implications in ventricular function. J Hypertens. 1993;11:327-37.
11. Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation. 1994;90:195-203.
12. Shapiro BP, Chen HH, Burnett JC, Redfield MM. Use of plasma brain natriuretic peptide concentration to aid in the diagnosis of heart failure. Mayo Clin Proc. 2003;78:481-6.
13. Mair J, Hammerer-Lercher A, Puschendorf B. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure. Clin Chem Lab Med. 2001;39:571-88.
14. Schultz M, Faber J, Kistorp C, Jarlov A, Pedersen F, Wiinberg N, et al. N-terminal-pro-B-type natriuretic peptide (NT-pro-BNP) in different thyroid function states. Clin Endocrinol. 2004;60:54-9.
15. Wei T, Zeng C, Tian Y, Chen Q, Wang L. B-type natriuretic peptide in patients with clinical hyperthyroidism. J Endocrinol Invest. 2005;28:8-11.
16. Kohno M, Horio T, Yasunari K, Yokokawa K, Ikeda M, Kurihara N, et al. Stimulation of brain natriuretic peptide release from the heart by thyroid hormone. Metabolism. 1993;42:1059-64.
17. McCullough PA, Omland T, Maisel AS. B-type natriuretic peptides: a diagnostic breakthrough for clinicians. Rev Cardiovasc Med. 2003;4:72-80.
18. Mueller T, Gegenhuber A, Poelz W, Haltmayer M. Biochemical diagnosis of impaired left ventricular ejection fraction - comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP). Clin Chem Lab Med. 2004;42:159-63.
19. Choi YH, Chung JH, Bae SW, Lee WH, Jeong EM, Kang MG, et al. Severe coronary artery spasm can be associated with hyperthyroidism. Coron Artery Dis. 2005;16:135-9.
20. Buckberg GD, Towers B, Paglia DE, Mulder DG, Maloney JV. Subendocardial ischemia after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1972;64:669-84.
21. Dorr M, Volzke H. Cardiovascular morbidity and mortality in thyroid dysfunction. Minerva Endocrinol. 2005;30:199-216.
22. Osman F, Gammage MD, Franklyn JA. Hyperthyroidism and cardiovascular morbidity and mortality. Thyroid. 2002;12:483-7.
23. Chen CH, Nevo E, Fetics B, Pak PH, Yin FC, Maughan WL, et al. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure: validation of generalized transfer function. Circulation. 1997;95:1827-36.
24. Pauca AL, O'Rourke MF, Kon ND. Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension. 2001;38:932-7.
25. O'Rourke M, Pauca A, Kon N. Generation of ascending aortic from radial artery pressure waveform. J Am Coll Cardiol. 2002;39 suppl B:177B.
26. Wilkinson IB, MacCallum H, Flint L, Cockcroft JR, Newby DE, Webb DJ. The influence of heart rate on augmentation index and central arterial pressure in humans. J Physiol. 2000;525:263-70.
27. Bodlaj G, Berg J, Biesenbach G. Diurnal variation of arterial stiffness and subendocardial perfusion noninvasively assessed using applanation tonometry in healthy young men. Wien Klin Wochenschr. 2005;117:348-52.
28. Bland JM, Altman DG. Statistics Notes. Measurement error. BMJ. 1996;313:744.
29. Obuobie K, Smith J, John R, Davies JS, Lazarus JH. The effects of thyrotoxicosis and its treatment on central arterial stiffness. Eur J Endocrinol. 2002;147:35-40.
30. O'Rourke M. Arterial stiffness, systolic blood pressure, and logical treatment of arterial hypertension. Hypertension. 1990;15:339-47.
31. Liang F, Webb P, Marimuthu A, Zhang S, Gardner DG. Triiodothyronine increases brain natriuretic peptide (BNP) gene transcription and amplifies endothelin-dependent BNP gene transcription and hypertrophy in neonatal rat ventricular myocytes. J Biol Chem. 2003;278:15073-83.
32. Noh JY, Hamada N, Inoue Y, Abe Y, Ito K, Ito K. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease. Thyroid. 2000;10:809-13.
33. Wilkinson IB, Franklin SS, Hall IR, Tyrrell S, Cockcroft JR. Pressure amplification explains why pulse pressure is unrelated to risk in young subjects. Hypertension. 2001;38:1461-6.
34. Chen JL, Chiu HW, Tseng YJ, Chu WC. Hyperthyroidism is characrerized by both increased sympathetic and decreased vagal modulation of heart rate: evidence from spectral analysis of heart rate variability. Clin Endocrinol. 2006;64:611-6.
35. Ojamaa K, Klemperer JD, Klein I. Acute effects of thyroid hormone on vascular smooth muscle. Thyroid. 1996;6:505-12.
36. Levey GS, Klein I. Catecholamine-thyroid hormone interactions and the cardiovascular manifestations of hyperthyroidism. Am J Med. 1990;88:642-6.
37. Benetos A, Waeber B, Izzo J, Mitchell G, Resnick L, Asmar R, et al. Influence of age, risk factors, and cardiovascular and renal disease on arterial stiffness: clinical applications. Am J Hypertens. 2002;15:1101-8.
38. Peters A, Ehlers M, Blank B, Exler D, Falk C, Kohlmann T, et al. Excess triiodothyronine as a risk factor of coronary events. Arch Intern Med. 2000;160:1993-9.
39. Fazio S, Palmieri EA, Lombardi G, Biondi B. Effects of thyroid hormone on the cardiovascular system. Recent Prog Horm Res. 2004;59:31-50.
40. Cohn JN. Arterial stiffness, vascular disease, and risk of cardiovascular events. Circulation. 2006;113:601-3.
41. Weber T, Auer J, O'Rourke MF, Kvas E, Lassnig E, Lamm G, et al. Increased arterial wave reflections predict severe cardiovascular events in patients undergoing percutaneous coronary interventions. Eur Heart J. 2005;26:2657-63.